BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Xiao R, Jin H, Huang F, Huang B, Wang H, Wang YG. Oncolytic virotherapy for hepatocellular carcinoma: A potent immunotherapeutic landscape. World J Gastrointest Oncol 2024; 16(7): 2867-2876 [PMID: 39072175 DOI: 10.4251/wjgo.v16.i7.2867]
URL: https://www.wjgnet.com/1948-5204/full/v16/i7/2867.htm
Number Citing Articles
1
Huimin Yuan, Ruochen Xu, Senlin Li, Mengzhu Zheng, Qingyi Tong, Ming Xiang, Yonghui Zhang. The Malignant Transformation of Viral Hepatitis to Hepatocellular Carcinoma: Mechanisms and InterventionsMedComm 2025; 6(3) doi: 10.1002/mco2.70121
2
Mingdong Lu, Wenqin Jiang, Zhekai Liu, Yiqing Liu, Fangli Wu, Weibo Jin. Development of a Dual Gene-Targeted Multi-Sirna with Branched Structure and Its Role in the Therapy of Liver CancerPharmaceuticals 2025; 18(12): 1844 doi: 10.3390/ph18121844
3
Mariam Ayad Abd, Mohammed Asiri, Shahd Rajab Farhan, Gaurav Sanghvi, Rangaswamy Roopashree, Aditya Kashyap, D. Alex Anand, Rajashree Panigrahi, Yasser Fakri Mustafa, Baneen C. Gabaal. Update on Application of Oncolytic Virus‐Based Combination Therapy in the Treatment of Hepatocellular CarcinomaJournal of Biochemical and Molecular Toxicology 2025; 39(6) doi: 10.1002/jbt.70327
4
Khulah Sadia, Annalisa Castagna, Silvia Udali, Francesca Ambrosani, Patrizia Pattini, Ruggero Beri, Giuseppe Argentino, Maria Masutti, Sara Moruzzi, Simonetta Friso. Epigenetic Regulation Through Histone Deacetylation: Implications and Therapeutic Potential in Hepatocellular CarcinomaCells 2025; 14(17): 1337 doi: 10.3390/cells14171337
5
Yanxi Luo, Zhigao Hu, Guoxiu Du, Wanpeng Xin, Minglong Wang. Novel immune checkpoint inhibitor FilC/PD-1 recombinant vaccinia virus inhibits hepatocellular carcinomaFrontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1622209